Is BridgeBio Pharma, Inc. (BBIO) a Buy, Sell, or Hold?
NASDAQ : BBIO
BridgeBio Pharma, Inc. — Institutional Ownership
$80.09 USD
-$2.05 (-2.5%)
- Volume
- 2.12M
- Average Volume
- 3.44M
- Market Capitalization
- $15.69B
- P/E Ratio
- -21.36
- Dividend Yield
- 0.00%
- Price Target
- $100.00
- Year High
- $93.42
- Year Low
- $42.09
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.44
Institutional Ownership Summary
Institutional Ownership %
1.56%
Investors Holding
112
change: -379 | last: 491
Increased Positions
64
change: -208 | last: 272
Reduced Positions
30
change: -107 | last: 137
New Positions
20
change: -69 | last: 89
Sold Positions
372
change: 302 | last: 70
Total Calls
134.6K
Total Puts
60000
Put-Call Ratio
0.45
change: 29.5366 | last: 0.1504
Total Invested
411.19M
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-07-10 | VIKING GLOBAL INVESTORS LP | 9.79M | 5.00% |
| 2026-07-10 | Shabet Rose Sharon | 9.79M | 5.00% |
| 2026-07-10 | HALVORSEN OLE ANDREAS | 9.79M | 5.00% |
| 2026-07-10 | Viking Global Opportunities Illiquid Investments Sub-Master LP | 9.79M | 5.00% |
| 2026-07-10 | Viking Global Opportunities Portfolio GP LLC | 9.79M | 5.00% |
| 2026-07-10 | Viking Global Opportunities GP LLC | 9.79M | 5.00% |
| 2026-07-10 | Viking Global Opportunities Parent GP LLC | 9.79M | 5.00% |
| 2026-05-29 | Farallon Capital Partners, L.P. | 728.24K | 0.40% |
| 2026-05-15 | JANUS HENDERSON GROUP PLC | 13.18M | 6.80% |
| 2026-04-16 | NEIL KUMAR | 9.28M | 4.60% |
| 2026-04-02 | Viking Global Opportunities Parent GP LLC | 11.84M | 6.10% |
| 2026-04-02 | Shabet Rose Sharon | 11.84M | 6.10% |
| 2026-04-02 | HALVORSEN OLE ANDREAS | 11.84M | 6.10% |
| 2026-04-02 | Viking Global Opportunities Illiquid Investments Sub-Master LP | 11.84M | 6.10% |
| 2026-04-02 | Viking Global Opportunities Portfolio GP LLC | 11.84M | 6.10% |
| 2026-04-02 | Viking Global Opportunities GP LLC | 11.84M | 6.10% |
| 2026-04-02 | VIKING GLOBAL INVESTORS LP | 11.84M | 6.10% |
| 2026-03-26 | The Vanguard Group | - | 0.00% |
| 2026-02-17 | Viking Global Opportunities Illiquid Investments Sub-Master LP | 13.03M | 6.80% |
| 2026-02-17 | HALVORSEN OLE ANDREAS | 13.03M | 6.80% |
| 2026-02-17 | JANUS HENDERSON GROUP PLC | 11M | 5.70% |
| 2026-02-17 | Viking Global Opportunities Parent GP LLC | 13.03M | 6.80% |
| 2026-02-17 | Viking Global Opportunities Portfolio GP LLC | 13.03M | 6.80% |
| 2026-02-17 | Viking Global Opportunities GP LLC | 13.03M | 6.80% |
| 2026-02-17 | Ott David C. | 13.03M | 6.80% |
| 2026-02-17 | Shabet Rose Sharon | 13.03M | 6.80% |
| 2026-02-17 | VIKING GLOBAL INVESTORS LP | 13.03M | 6.80% |
| 2025-11-14 | Viking Global Opportunities GP LLC | 15.89M | 8.20% |
| 2025-11-14 | T. Rowe Price Associates, Inc. | 885.04K | 1.10% |
| 2025-11-14 | VIKING GLOBAL INVESTORS LP | 15.89M | 8.20% |
| 2025-11-14 | VIKING GLOBAL PERFORMANCE LLC | - | 0.00% |
| 2025-11-14 | Viking Global Equities II LP | - | 0.00% |
| 2025-11-14 | Viking Global Equities Master Ltd. | - | 0.00% |
| 2025-11-14 | Viking Long Fund GP LLC | - | 0.00% |
| 2025-11-14 | Viking Long Fund Master Ltd. | - | 0.00% |
| 2025-11-14 | Viking Global Opportunities Parent GP LLC | 15.89M | 8.20% |
| 2025-11-14 | Viking Global Opportunities Portfolio GP LLC | 15.89M | 8.20% |
| 2025-11-14 | Viking Global Opportunities Illiquid Investments Sub-Master LP | 15.89M | 8.20% |
| 2025-11-14 | Viking Global Opportunities Liquid Portfolio Sub-Master LP | - | 0.00% |
| 2025-11-14 | HALVORSEN OLE ANDREAS | 15.89M | 8.20% |
| 2025-11-14 | Ott David C. | 15.89M | 8.20% |
| 2025-11-14 | Shabet Rose Sharon | 15.89M | 8.20% |
| 2025-08-14 | Viking Long Fund Master Ltd. | 77532.0 | 0.04% |
| 2025-08-14 | VIKING GLOBAL PERFORMANCE LLC | 213K | 0.10% |
| 2025-08-14 | Viking Global Opportunities Parent GP LLC | 17.49M | 9.10% |
| 2025-08-14 | Viking Global Opportunities GP LLC | 17.49M | 9.10% |
| 2025-08-14 | Viking Global Opportunities Portfolio GP LLC | 17.49M | 9.10% |
| 2025-08-14 | VIKING GLOBAL INVESTORS LP | 17.78M | 9.30% |
| 2025-08-14 | Viking Global Equities II LP | 4260.0 | 0.00% |
| 2025-08-14 | Viking Global Equities Master Ltd. | 208.74K | 0.10% |
| 2025-08-14 | Viking Long Fund GP LLC | 77532.0 | 0.04% |
| 2025-08-14 | Shabet Rose Sharon | 18.6M | 9.70% |
| 2025-08-14 | Ott David C. | 18.6M | 9.70% |
| 2025-08-14 | HALVORSEN OLE ANDREAS | 18.6M | 9.70% |
| 2025-08-14 | Viking Global Opportunities Illiquid Investments Sub-Master LP | 17.46M | 9.10% |
| 2025-08-14 | Viking Global Opportunities Liquid Portfolio Sub-Master LP | 32802.0 | 0.02% |
| 2025-07-29 | The Vanguard Group | 16.48M | 8.68% |
| 2025-07-01 | Viking Global Opportunities Parent GP LLC | 18.15M | 9.60% |
| 2025-07-01 | VIKING GLOBAL INVESTORS LP | 18.6M | 9.80% |
| 2025-07-01 | VIKING GLOBAL PERFORMANCE LLC | 339.7K | 0.20% |
| 2025-07-01 | Viking Global Equities II LP | 6794.0 | 0.00% |
| 2025-07-01 | Viking Global Equities Master Ltd. | 332.9K | 0.20% |
| 2025-07-01 | Viking Long Fund GP LLC | 118.21K | 0.10% |
| 2025-07-01 | Viking Long Fund Master Ltd. | 118.21K | 0.10% |
| 2025-07-01 | Viking Global Opportunities GP LLC | 18.15M | 9.60% |
| 2025-07-01 | Viking Global Opportunities Portfolio GP LLC | 18.15M | 9.60% |
| 2025-07-01 | Viking Global Opportunities Illiquid Investments Sub-Master LP | 18.09M | 9.50% |
| 2025-07-01 | Viking Global Opportunities Liquid Portfolio Sub-Master LP | 55031.0 | 0.03% |
| 2025-07-01 | HALVORSEN OLE ANDREAS | 18.6M | 9.80% |
| 2025-07-01 | Ott David C. | 18.6M | 9.80% |
| 2025-07-01 | Shabet Rose Sharon | 18.6M | 9.80% |
| 2025-05-14 | KKR Genetic Disorder L.P. | 13.26M | 7.00% |
| 2025-05-14 | George R. Roberts | 13.26M | 7.00% |
| 2025-05-14 | Henry R. Kravis | 13.26M | 7.00% |
| 2025-05-14 | KKR Management LLP | 13.26M | 7.00% |
| 2025-05-14 | KKR & Co. Inc. | 13.26M | 7.00% |
| 2025-05-14 | KKR Group Co. Inc. | 13.26M | 7.00% |
| 2025-05-14 | KKR Group Holdings Corp. | 13.26M | 7.00% |
| 2025-05-14 | KKR Group Partnership L.P. | 13.26M | 7.00% |
| 2025-05-14 | KKR Genetic Disorder GP LLC | 13.26M | 7.00% |
| 2025-03-12 | VIKING GLOBAL INVESTORS LP | 22.06M | 11.70% |
| 2025-03-12 | Viking Global Equities Master Ltd. | 487.9K | 0.30% |
| 2025-03-12 | Viking Long Fund GP LLC | 194.18K | 0.10% |
| 2025-03-12 | Viking Long Fund Master Ltd. | 194.18K | 0.10% |
| 2025-03-12 | Viking Global Opportunities Parent GP LLC | 21.37M | 11.30% |
| 2025-03-12 | Viking Global Opportunities GP LLC | 21.37M | 11.30% |
| 2025-03-12 | Viking Global Opportunities Portfolio GP LLC | 21.37M | 11.30% |
| 2025-03-12 | Viking Global Opportunities Illiquid Investments Sub-Master LP | 21.37M | 11.30% |
| 2025-03-12 | HALVORSEN OLE ANDREAS | 22.06M | 11.70% |
| 2025-03-12 | Ott David C. | 22.06M | 11.70% |
| 2025-03-12 | Shabet Rose Sharon | 22.06M | 11.70% |
| 2025-03-12 | VIKING GLOBAL PERFORMANCE LLC | 487.9K | 0.30% |
| 2025-03-07 | KKR Genetic Disorder L.P. | 19.26M | 10.10% |
| 2025-02-13 | NEIL KUMAR | 10.47M | 5.41% |
| 2025-01-31 | Viking Global Opportunities GP LLC | 21.37M | 11.30% |
| 2025-01-31 | Viking Global Opportunities Illiquid Investments Sub-Master LP | 21.37M | 11.30% |
| 2025-01-31 | HALVORSEN OLE ANDREAS | 22.06M | 11.70% |
| 2025-01-31 | Ott David C. | 22.06M | 11.70% |
| 2025-01-31 | Shabet Rose Sharon | 22.06M | 11.70% |
| 2025-01-31 | VIKING GLOBAL INVESTORS LP | 22.06M | 11.70% |
| 2025-01-31 | VIKING GLOBAL PERFORMANCE LLC | 487.9K | 0.30% |
| 2025-01-31 | Viking Global Equities Master Ltd. | 487.9K | 0.30% |
| 2025-01-31 | Viking Long Fund GP LLC | 194.18K | 0.10% |
| 2025-01-31 | Viking Long Fund Master Ltd. | 194.18K | 0.10% |
| 2025-01-31 | Viking Global Opportunities Parent GP LLC | 21.37M | 11.30% |
| 2025-01-31 | Viking Global Opportunities Portfolio GP LLC | 21.37M | 11.30% |
| 2024-10-22 | (1) BlackRock, Inc. | 12.88M | 6.80% |
| 2023-07-20 | Viking Global Equities Master Ltd. | 631.17K | 0.40% |
| 2023-07-20 | Viking Global Performance LLC | 631.17K | 0.40% |
| 2023-07-20 | Viking Global Investors LP | 25.12M | 15.70% |
| 2023-07-20 | Rose S. Shabet | 25.12M | 15.70% |
| 2023-07-20 | David C. Ott | 25.12M | 15.70% |
| 2023-07-20 | O. Andreas Halvorsen | 25.12M | 15.70% |
| 2023-07-20 | Viking Global Opportunities Illiquid Investments Sub-Master LP | 24.24M | 15.10% |
| 2023-07-20 | Viking Global Opportunities Portfolio GP LLC | 24.24M | 15.10% |
| 2023-07-20 | Viking Global Opportunities Parent GP LLC | 24.24M | 15.10% |
| 2023-07-20 | Viking Long Fund Master Ltd. | 251.2K | 0.20% |
| 2023-07-20 | Viking Long Fund GP LLC | 251.2K | 0.20% |
| 2023-07-20 | Viking Global Opportunities GP LLC | 24.24M | 15.10% |
| 2023-02-08 | STATE STREET CORPORATION | 8.84M | 5.92% |
| 2022-02-09 | The Vanguard Group - 23-1945930 | 9.33M | 6.34% |
| 2022-02-03 | (1) BlackRock, Inc. | 9.28M | 6.30% |
| 2021-02-16 | Perceptive Advisors LLC | 6.71M | 5.50% |
| 2021-02-16 | Perceptive Life Sciences Master Fund, Ltd. | 6.71M | 5.50% |
| 2021-02-16 | Joseph Edelman | 6.71M | 5.50% |
| 2021-02-16 | NEIL KUMAR | 8.33M | 6.74% |
| 2021-02-10 | The Vanguard Group - 23-1945930 | 6.44M | 5.25% |
| 2021-02-05 | (1) BlackRock, Inc. | 6.52M | 5.30% |
| 2020-10-15 | Eidos Therapeutics, Inc. | 44.65M | 36.40% |
| 2020-02-14 | NEIL KUMAR | 8.62M | 6.98% |
| 2020-02-14 | Management (U.S.), LLC | 6.73M | 5.50% |
| 2019-07-11 | 5.5% | 6.59M | 5.50% |
| 2019-07-11 | 10 | 6.59M | 5.50% |
| 2019-07-11 | 10 | 6.59M | 5.50% |
| 2019-07-08 | Viking Global Opportunities Portfolio GP LLC | 25.74M | 21.40% |
| 2019-07-08 | Viking Long Fund Master Ltd. | 251.2K | 0.20% |
| 2019-07-08 | Viking Long Fund GP LLC | 251.2K | 0.20% |
| 2019-07-08 | Rose S. Shabet | 26.62M | 22.10% |
| 2019-07-08 | Viking Global Investors LP | 26.62M | 22.10% |
| 2019-07-08 | David C. Ott | 26.62M | 22.10% |
| 2019-07-08 | Viking Global Equities Master Ltd. | 631.17K | 0.50% |
| 2019-07-08 | Viking Global Performance LLC | 631.17K | 0.50% |
| 2019-07-08 | Viking Global Opportunities GP LLC | 25.74M | 21.40% |
| 2019-07-08 | O. Andreas Halvorsen | 26.62M | 22.10% |
| 2019-07-08 | Viking Global Opportunities Illiquid Investments Sub-Master LP | 25.74M | 21.40% |
BBIO Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $76.49 | 197.24M | $15.09B | $570.12M | $2.73B | $17.25B |
| 2024-12-31 | $27.44 | 186.08M | $5.11B | $681.1M | $1.73B | $6.16B |
| 2023-12-31 | $40.37 | 162.79M | $6.57B | $375.94M | $1.74B | $7.94B |
| 2022-12-31 | $7.62 | 147.47M | $1.12B | $376.69M | $1.72B | $2.47B |
| 2021-12-31 | $16.68 | 144.36M | $2.41B | $393.77M | $1.73B | $3.74B |
| 2020-12-31 | $71.11 | 118M | $8.39B | $356.08M | $495.79M | $8.53B |
| 2019-12-31 | $35.05 | 105.1M | $3.68B | $363.77M | $91.79M | $3.41B |
| 2018-12-31 | $27.55 | 92.33M | $2.54B | $436.09M | $54.51M | $2.16B |
| 2017-12-31 | $27.55 | 92.33M | $2.54B | $92M | $143.87M | $2.6B |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $74.26 | 194.79M | $14.47B | $879.89M | $3.38B | $16.97B |
| 2025-12-31 | $76.49 | 197.24M | $15.09B | $570.12M | $2.73B | $17.25B |
| 2025-09-30 | $51.94 | 190.52M | $9.9B | $642.95M | $1.86B | $11.11B |
| 2025-06-30 | $43.18 | 190.52M | $8.23B | $749.4M | $2.68B | $10.15B |
| 2025-03-31 | $34.57 | 190.14M | $6.57B | $540.6M | $1.86B | $7.89B |
| 2024-12-31 | $27.44 | 189.44M | $5.2B | $681.1M | $1.73B | $6.25B |
| 2024-09-30 | $25.46 | 188.51M | $4.8B | $266.32M | $1.73B | $6.26B |
| 2024-06-30 | $25.20 | 187.59M | $4.73B | $547.37M | $1.73B | $5.91B |
| 2024-03-31 | $29.98 | 178.71M | $5.36B | $475.35M | $1.73B | $6.61B |
| 2023-12-31 | $40.37 | 174.46M | $7.04B | $375.94M | $1.74B | $8.41B |
| 2023-09-30 | $26.37 | 163.31M | $4.31B | $505.21M | $1.74B | $5.54B |
| 2023-06-30 | $17.20 | 160.54M | $2.76B | $302.44M | $1.73B | $4.19B |